EP2173345
Lyfjaform af metadoxín til inntöku
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.7.2008EP published:
19.8.2015EP application number:
08763673.4
EP translation filed:
21.10.2015Grant published:
15.11.2015EPO information:
European Patent Register
Max expiry date:
2.7.2028Expiry date:
2.7.2017
Title:
ORAL FORMULATION OF METADOXINE
Timeline
Today
3.7.2008EP application
19.8.2015EP Publication
21.10.2015Translation submitted
15.11.2015Registration published
2.7.2017Expires
Owner
Name:
Alcobra Ltd.Address:
65 Rothschild Blvd., 65785, Tel Aviv, IL
Inventor
Name:
MEGIDDO, GurAddress:
M.p. Judean Hills, IL
Name:
MEGIDDO, DaliaAddress:
M.p. Judean Hills, IL
Name:
YAMIN, RinaAddress:
Rehovot, IL
Name:
ILAN, YaronAddress:
Jerusalem, IL
Name:
AMSELEM, ShimonAddress:
Rehovot, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
18438907Date:
3.7.2007Country:
IL
Number:
18715907Date:
5.11.2007Country:
IL
Classification
Categories:
A61K 31/44, A61K 31/455, A61P 25/32, A61K 9/46, A61K 9/00, A61K 9/16, A61K 9/20, A61K 9/50, A61K 9/70
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.6.2016
Expires: 2.7.2017
Payer: Árnason Faktor